Live Online Training: Stability Testing for Drug Substances and Drug Products

Live Online Training: Stability Testing for Drug Substances and Drug Products

Course No 18469

All times mentioned are CET.

Costs

There is no recording available for this Online Training. Are you interested in participating in an upcoming date of this Live Online Training? Would you like to get individual advice on our training portfolio? Contact us.

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Speakers

Dr Thomas Fürst, Boehringer Ingelheim Pharma, Germany
Dr Wolfgang Grimm, Germany
Dr Cornelia Nopitsch-Mai, Quality Assessor, Germany
Dr Jordi Ruiz-Combalia, Audit GMP, Spain
Dr Thomas Uhlich, Bayer, Germany

Objectives

This Live Online Training is intended to provide information on different aspects of stability testing.

The event will be opened by an overview of stability testing with a special focus on important changes in current revisions of ICH Guidelines. In the subsequent presentations, practical aspects of stability testing for drug substances and throughout drug development are discussed. Furthermore, stability testing for drug products and a risk based approach for stability testing covering different climatic zones are presented. In addition, the specific challenges of data evaluation will be addressed.

Background

Analytical methods that were not “stability-indicating” are frequently cited in FDA 483s and Warning Letters. This Live Online Training will thus address how to set impurity limits for related substances and degradation products based on method capability and stability results.

The analytical result, which will be compared to the specification, is affected by the variability of the measurement itself and depends also on the sampling process and on the variability of the manufacturing process of the tested product itself. This makes statistical considerations essential and consideration of the associated measurement uncertainties vital when setting or complying with specifications.

Target Group

This Live Online Training is of particular interest to specialists from QA, QC and Regulatory Affairs departments of the API and pharmaceutical industry and CROs as well as to members of the EU inspectorates and authorities.

During the Q&A sessions, participants have the opportunity to exchange their experiences they gained with the different aspects of ‘specifications’ with the experts from the API and pharmaceutical industry as well as with members of competent authorities.

Technical Requirements

For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings.

At https://www.webex.com/test-meeting.html you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in. Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.

Programme

09.00 – 09.15 h
Introduction
 
09.15 – 10.45 h
Current ICH and CHMP Guidelines for Stability Testing
  • Overview of Stability Guidelines
  • Concepts of Stability testing
  • Retest period and Shelf-life
  • Post-marketing Stability Studies
  • Future Activities
10.45 – 11.00 h
Break

11.00 – 12.00 h
Stability Testing throughout Drug Development
  • Must the development stability programme meet ICH Q1A?
  • Stability testing from early development to product launch
  • Clinical stability for comparators
  • Site specific stability
12.00 – 13.00 h
Break

13.00 – 14.00 h
Stability Testing for Drug Substances
  • Stability protocols
  • Stress testing
  • Photostability testing
  • Documentation
14.00 – 14.15 h
Break

14.15 – 15.15 h
Stability Testing for Drug Products
  • Strategy of Stability Testing
  • Performance of new Drug Products
  • Related Finished Products with existing substances
  • Follow-up Stability Testing
15.15 – 15.30 h
Break

15.30 – 16.30 h
Evaluation of Stability Results – Statistical Considerations
  • Sample number and replication
  • Trend analysis
  • Outliers
  • Pooling of batch data
  • Shelf life prediction

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK